Number of Portfolio Companies 10
Number of Exits 
Unlock for free
  • Investor Type  Investment Partner, Individual/Angel
  • Investor Stage  Seed
  • Number of Exits 
Patrick Soon-Shiong is the Executive Chairman of ImmunityBio. He previously worked at Wibbitz as a Board member. Patrick Soon-Shiong attended the University of the Witwatersrand.
Number of Investments 12
Patrick Soon-Shiong has made 12 investments. Their latest investment was Series A - Sienza Energy on Feb 17, 2022, when
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
Feb 17, 2022
Sienza Energy
Yes
Series A - Sienza Energy
Apr 8, 2020
Heliogen
Series A - Heliogen
$25M
Mar 26, 2019
NantKwest
Post-IPO Equity - NantKwest
$39M
Jan 30, 2019
Directa Plus
Yes
Post-IPO Equity - Directa Plus
Oct 9, 2018
Heliogen
Series A - Heliogen
$10M
Jun 2, 2015
ImmunityBio
Yes
Private Equity Round - ImmunityBio
$75M
Feb 4, 2015
Zoom
No
Series C - Zoom
$30M
Jul 18, 2014
NantMobile
Yes
Venture Round - NantMobile
$30M
Nov 29, 2013
Fluential
Yes
Series A - Fluential
$2M
Sep 24, 2013
Zoom
No
Series B - Zoom
$6.5M
Number of Partner Investments 7
Announced Date  
Organization Name  
Investor Name  
Lead Investor  
Funding Round  
Money Raised  
Jan 19, 2018
PacketFabric
NantCapital
Yes
Series B - PacketFabric
$25M
Oct 23, 2017
Wibbitz
NantMobile
Series C - Wibbitz
$20M
May 21, 2015
Wibbitz
NantMobile
Yes
Series B - Wibbitz
$8M
Jan 1, 2015
NantiBodyFc
NantWorks
Yes
Private Equity Round - NantiBodyFc
$10M
Oct 1, 2014
Keyssa
NantWorks
Series C - Keyssa
$25M
Jul 1, 2011
Keyssa
NantWorks
Series B - Keyssa
$5M
May 1, 2010
Keyssa
NantWorks
Series A - Keyssa
$2M
Number of Exits 
Unlock for free
Patrick Soon-Shiong has exits. Their most notable exits are ZoomPrizeo, and NantKwest.
  • Zoom Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing.
  • Prizeo Prizeo is a platform for celebrities to raise funds for charitable causes by offering rewards and exciting experiences to donors.
  • NantKwest NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.
  • ImmunityBio ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.
  • Heliogen Heliogen is a renewable energy technology company unlocking the power of sunlight to replace fossil fuels.
  • Directa Plus Directa Plus is a nanotechnology company developing innovative manufacturing processes for the production of nanostructures.
Number of Current Jobs 15
Number of Past Jobs 2
Patrick Soon-Shiong has 15 current jobs including Executive Chairman of the Board at ImmunityBio, Founder and Executive Chairman at ImmunityBio, and CEO & Founder at Adeptence. Additionally, Patrick Soon-Shiong has had 2 past jobs including CEO and Founder at Abraxis BioScience.
Organization Name  
Title At Company  
Start Date  
End Date  
Abraxis BioScience
CEO and Founder2007
NantKwest
Founder2002
Number of Current Board & Advisor Roles 4
Number of Past Board & Advisor Roles 1
Patrick Soon-Shiong holds 4 board and advisor roles including Scientific Advisor at Five3 Genomics, Chairman of the Board of Directors at Abraxis BioScience, and Board Of Director at Viracta Therapeutics.
Organization Name  
Title At Company  
Start Date  
End Date  
Wibbitz
Board Member20142021
Number of News Articles 444
Funding RoundFeb 17, 2022
NewsJul 26, 2021
Los Angeles Business Journal — ImmunityBio Shares Swoon After Merger
NewsJul 19, 2021
NewsMay 17, 2021
Los Angeles Business Journal — LABJ Insider: Soon-Shiong Gives Back Abroad